P. Gordon

Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies

T. Takken, B. Gualano, B. Feldman, 2016, The Journal of Rheumatology.

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

D. Isenberg, P. Machado, M. Hanna, 2022, Rheumatology.

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

C. Gordon, K. Payne, D. Morris, 2023, Arthritis Research & Therapy.

A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease

Patrick Gordon, J. Galloway, A. Buazon, 2022, The Journal of Rheumatology.

Effect of UBE2L3 genotype on regulation of the linear ubiquitin chain assembly complex in systemic lupus erythematosus

T. Spector, P. Lehner, T. Vyse, 2015, The Lancet.

Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.

Antoni B. Chan, I. Bruce, C. Gordon, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

C. Gordon, K. Payne, D. Morris, 2023, Arthritis Research & Therapy.

P090 Validation of hospital episode statistics data to enable national registration of idiopathic inflammatory myopathies

M. Bythell, E. Peach, J. Galloway, 2021 .